THE AMERICAN COLLEGE OF RADIOLOGY and several colorectal cancer care advocacy groups urged Congress to pass the CT Colonography Screening for Colorectal Cancer Act, which would provide Medicare coverage for seniors who choose those screening exams.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL, The Scripps Research Institute and other institutions launched the Human Dark Proteome Initiative, to focus on the portion of the proteome that does not adopt defined 3D structures.
SIDNEY KIMMEL CANCER CENTER at Johns Hopkins University made several personnel changes.
CITY OF HOPE announced several appointments to its faculty.
STUART ORKIN received Boston Children's Hospital's Lifetime Impact Award at the hospital's third annual Global Pediatric Innovation Summit.
EDITH PEREZ was named vice president and head of Genentech/Roche BioOncology U.S. Medical Affairs. Perez stepped down as vice chair of the Alliance for Clinical Trials in Oncology.
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH launched an international genomic and clinical data sharing initiative, known as AACR Project Genomics, Evidence, Neoplasia, Information, Exchange—or GENIE. The initial phase of the project, which is being conducted in partnership with seven global leaders in genomic sequencing for clinical utility as well as two informatics partners, will aggregate […]
NCI recognized 11 investigators nationwide with its Cancer Clinical Investigator Team Leadership Awards. The awards support clinical investigators at NCI-designated cancer centers who participate in NCI-funded clinical trials. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. The award provides partial salary support for 2 years for the […]
STAND UP TO CANCER, Cancer Research UK and the Lustgarten Foundation selected members for a Dream Team focused on pancreatic cancer. Daniel Von Hoff, physician-in-chief and distinguished professor at the Translational Genomics Research Institute in Phoenix, chief scientific officer at HonorHealth, and professor of medicine at the Mayo Clinic, will lead the team—with Ronald Evans, […]
SRI INTERNATIONAL was awarded a contract of up to $9 million to provide preclinical development services to the NCI PREVENT Cancer Program. Under the contract, SRI will provide scientific expertise, modern testing and support facilities, and analytical instrumentation to conduct a wide variety of preclinical pharmacology and toxicology studies to evaluate potential cancer prevention drugs. […]
